FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, clinical laboratory diagnostics, and can be used to diagnose Parkinson's disease. For this purpose, peripheral blood is sampled, a CD45+ homogeneous cell fraction is separated with lysis of the separated cell fraction. In the CD45+ cell lysate, a concentration of the oligomeric alpha-synuclein is measured and at a concentration greater than 2.7 pg/ml, Parkinson's disease is diagnosed.
EFFECT: invention allows diagnosing Parkinson's disease, and forming risk groups among persons with a lack of neurological disorders.
1 cl, 3 ex, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSING PARKINSON'S DISEASE ASSOCIATED WITH MUTATIONS IN GLUCOCEREBROSIDASE (GBA) GENE | 2020 |
|
RU2750357C1 |
| METHOD FOR EARLY PRECLINICAL DIAGNOSTICS OF PARKINSON'S DISEASE BY CONCENTRATION OF CATECHOLAMINES IN PATIENT'S LACRIMAL FLUID | 2019 |
|
RU2775261C2 |
| PROTOFIBRIL-BINDING ANTIBODIES AND USE THEREOF IN THERAPEUTIC AND DIAGNOSTIC METHODS FOR PARKINSON'S DISEASE, DEMENTIA WITH LEWY BODIES AND OTHER ALPHA-SYNUCLEINOPATHIES | 2011 |
|
RU2555526C2 |
| METHOD FOR EARLY DIAGNOSIS OF PARKINSON'S DISEASE | 2019 |
|
RU2722666C1 |
| METHOD OF REDUCING MANIFESTATION OF NON-MOTOR SYMPTOMS IN PATIENTS WITH PARKINSON'S DISEASE | 2019 |
|
RU2734718C1 |
| LACTOBACILLUS FERMENTUM U-21 STRAIN, WHICH PRODUCES COMPLEX OF BIOLOGICALLY ACTIVE SUBSTANCES WHICH NEUTRALIZE SUPEROXIDE ANION INDUCED BY CHEMICAL AGENTS | 2018 |
|
RU2705250C2 |
| DIAGNOSTIC METHOD OF POSTURAL DISORDERS IN PARKINSON'S DISEASE | 2020 |
|
RU2733037C1 |
| METHOD FOR PREDICTION OF DEVELOPING NEURODEGENERATIVE DISEASES, UNDERLYING THE PATHOGENESIS OF WHICH IS GAMMA-SYNUCLEINOPATHY | 2018 |
|
RU2703430C1 |
| DIAGNOSTIC TECHNIQUE FOR PARKINSON DISEASE IN PATIENTS WITH OLFACTORY DYSFUNCTION | 2011 |
|
RU2478209C1 |
| METHOD OF OBTAINING POPULATION OF DOPAMINERGIC NEURONS FROM SUBSTANCE NIGRA OF MICE UNDER NORMAL AND PATHOLOGICAL CONDITIONS AND USE OF OBTAINED POPULATION FOR MOLECULAR BIOLOGICAL ANALYSIS | 2022 |
|
RU2811815C2 |
